Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein

NCT05194423 is registered in ClinicalTrials.gov with Changhai Hospital as lead sponsor.

NCT NCT05194423
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05194423 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
THE TRAVEL II TRIAL: Transcatheter Right Atrial-ventricular Valve rEplacement With LuX-Valve Via Jugular Vein
Lead sponsor
Changhai Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
March 1, 2022
Completion date
March 31, 2027
Enrollment
150 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid valve regurgitation